Circulating serum vitamin D levels in relation to metabolic syndrome in children: A systematic review and dose-response meta-analysis of epidemiologic studies
Review Obes Rev. 2021 Jul 6. doi: 10.1111/obr.13314
Parisa Rouhani 1 2, Zahra Hajhashemy 1 2, Parvane Saneei 2
Metabolic Syndrome has the following
See also
- Overview Metabolic Syndrome and vitamin D
- Overview Diabetes and vitamin D
- Overview Obesity and Vitamin D
- Diabetes, Metabolic Syndrome and Magnesium - many studies
- Arteries and Atherosclerosis and Vitamin D - many studies
- Metabolic Syndrome risk decreases by 20 percent with each 10 ng increase in Vitamin D - April 2021
- Metabolic Syndrome and Vitamin D - review of 33 studies - March 2021
- Metabolic Syndrome far less likely if high Vitamin D – 3 meta-analyses 2021
- Metabolic Syndrome 11X more likely if have a poor Vitamin D Receptor – 2018
- Vitamin D is linked to metabolic syndrome and obesity – Aug 2019
- Risk of Metabolic syndrome for senior women reduced 42 percent by 1,000 IU of vitamin D – RCT June 2019
- Metabolic Syndrome risk reduced 3.7 X by nuts (Magnesium, Omega-3) – Dec 2018
- Metabolically Healthy – only 1 in 50 seniors in the US – Nov 2018
- Metabolic Syndrome indicators inversely proportional to vitamin D below 46 ng – Nov 2018
- Metabolic Syndromes fought by Vitamin D in 6 ways – Oct 2023
Items in both categories Metabolic Syndrome and Meta-analysis are listed here:
- T1 Diabetes increased by 27% by second year of COVID – meta-analysis June 2023
- Some measures of metabolic syndrome are decreased by Vitamin D (may need Mg) – meta-analysis Oct 2022
- Metabolic syndrome risk in children decreased 12 percent for each 10 ng increase in Vitamin D – meta-analysis July 2021
- Metabolic Syndrome far less likely if high Vitamin D – 3 meta-analyses 2021
- Metabolic Syndrome 13 percent more likely for every 10 ng less vitamin D – Meta-analysis Jan 2014
- Metabolic Syndrome in children is associated with low vitamin D – review Jan 2013
Items in both categories Metabolic Syndrome and Children are listed here:
Findings from epidemiologic studies that evaluated the relationship between serum vitamin D levels and metabolic syndrome (MetS) in children were contradictory. We conducted a systematic review and meta-analysis on the relation of serum 25(OH)D levels and MetS in children. A comprehensive search was conducted in electronic databases, up to November 2020. Eleven cross-sectional studies that reported the link between circulating vitamin D levels and MetS in children were included in the analysis. Combining 11 effect sizes from 11 cross-sectional studies with 22,196 participants revealed that highest versus lowest serum vitamin D concentration was significantly associated with a 50% reduced odds of MetS in children (OR: 0.50; 95%CI: 0.39, 0.64). Subgroup analysis by study location revealed decreased odds of MetS in both non-Asian (OR: 0.45; 95%CI: 0.33, 0.63) and Asian countries (OR: 0.54; 95%CI: 0.39, 0.76) with no heterogeneity in these subgroups. When we confined the studies to those with representative populations (n = 21,611), a significant inverse association was found between highest versus lowest circulating vitamin D level and MetS (OR: 0.55; 95%CI: 0.42, 0.71).
Dose-response analysis showed that each 10 ng/ml (or 25 nmol/L) in serum vitamin D was linearly related to a 12% reduced odds of MetS (OR: 0.88; 95%CI: 0.78, 0.99) in children. A nonlinear association was also detected between serum 25(OH)D and MetS. This meta-analysis revealed that circulating vitamin D concentration was inversely associated with odds of MetS in children, in a dose-response fashion. The same finding was found in the studies with representative populations.
REFERENCES
- Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol: WJG. 2011;17(26):3082-3091.
- Potenza MV, Mechanick JI. The metabolic syndrome: definition, global impact, and pathophysiology. Nutr Clin Pract. 2009;24(5):560-577.
- Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23(4):465-471.
- Räikkönen K, Matthews KA, Salomon K. Hostility predicts metabolic syndrome risk factors in children and adolescents. Health Psychol. 2003;22(3):279-286.
- Friend A, Craig L, Turner S. The prevalence of metabolic syndrome in children: a systematic review of the literature. Metab Syndr Relat Disord. 2013;11(2):71-80. https://doi.org/10.1089/met.2012.0122
- Marangos P, Okamoto L, Caro J, Preedy V, Watson R. Economic Burden of the Components of the Metabolic Syndrome. In: Handbook of Disease Burdens and Quality of Life Measures. New York, NY: Springer; 2010.
- Shukla P, Palta S, Gupta A, Sehgal VK. Analysis of cost of medical therapy in patients of metabolic syndrome: an observational study. Int J Res Med Sci. 2018;6(2):443-447.
- Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC. Prevalence of obesity and severe obesity in US children, 1999-2016. Pediatrics. 2018;141(3):e20173459.
- Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766-781.
- Higuita-Gutiérrez LF, Quiroz WDJM, Cardona-Arias JA. Prevalence of metabolic syndrome and its association with sociodemographic characteristics in participants of a public chronic disease control program in Medellin, Colombia, in 2018. Diab Metab Syn Obes: Target Ther. 2020;13:1161-1169.
- Goyal RK, Shah VN, Saboo BD, et al. Prevalence of overweight and obesity in Indian adolescent school going children: its relationship with socioeconomic status and associated lifestyle factors. J Assoc Physicians India. 2010;58:151-158.
- Smetanina N, Albaviciute E, Babinska V, et al. Prevalence of overweight/obesity in relation to dietary habits and lifestyle among 7-17 years old children and adolescents in Lithuania. BMC Public Health. 2015;15(1):1-9.
- Kursawe R, Santoro N. Metabolic syndrome in pediatrics. Adv Clin Chem. 2014;65:91-142. https://doi.org/10.1016/b978-0-12-800141-7.00004-8
- Carlson JJ, Eisenmann JC, Norman GJ, Ortiz KA, Young PC. Dietary fiber and nutrient density are inversely associated with the metabolic syndrome in US adolescents. J Am Diet Assoc. 2011;111(11):1688-1695.
- Kelishadi R, Ardalan G, Motlagh ME, et al. National report on the association of serum vitamin D with cardiometabolic risk factors in the pediatric population of the Middle East and North Africa (MENA): the CASPIAN-III Study. Nutrition. 2014;30(1):33-38.
- Gupta N, Shah P, Nayyar S, Misra A. Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr. 2013;80(1):28-37.
- Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev. 2007;29(1):62-76.
- Reinehr T, Kleber M, Toschke AM. Lifestyle intervention in obese children is associated with a decrease of the metabolic syndrome prevalence. Atherosclerosis. 2009;207(1):174-180.
- Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26(5):573-580.
- Boucher B, Mannan N, Noonan K, Hales C, Evans S. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239-1245.
- Scragg R, Sowers M, Bell C, Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes Care. 2004;27(12):2813-2818.
- Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005;28(5):1228-1230.
- Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics. 2009;123(3):797-803.
- Eggemoen ÅR, Knutsen KV, Dalen I, Jenum AK. Vitamin D status in recently arrived immigrants from Africa and Asia: a cross-sectional study from Norway of children, adolescents and adults. BMJ Open. 2013;3(10):e003293.
- Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;1-16.
- Murni IK, Sulistyoningrum DC, Oktaria V. Association of vitamin D deficiency with cardiovascular disease risk in children: implications for the Asia Pacific Region. Asia Pac J Clin Nutr. 2016;25(Suppl 1):S8-s19. https://doi.org/10.6133/apjcn.122016.s1
- Bener A, Al-Ali M, Hoffmann GF. Vitamin D deficiency in healthy children in a sunny country: associated factors. Int J Food Sci Nutr. 2009;60(sup5):60-70.
- Albert Perez E, Mateu Olivares V, Martínez-Espinosa RM, Molina Vila MD, Reig G-GM. New insights about how to make an intervention in children and adolescents with metabolic syndrome: diet, exercise vs. changes in body composition. A systematic review of RCT. Nutrients. 2018;10(7):878.
- Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL. Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity. 2011;19(11):2214-2221.
- Cabral M, Araújo J, Teixeira J, et al. Vitamin D levels and cardiometabolic risk factors in Portuguese adolescents. Int J Cardiol. 2016;220:501-507.
- Gannagé-Yared M-H, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol. 2009;160(6):965-971.
- Kwon JH, Lee SE, Lee HA, et al. Relationship of serum 25-Hydroxyvitamin D (25 OH D) levels and components of metabolic syndrome in prepubertal children. Nutrition. 2015;31(11-12):1324-1327.
- Lee S, Kim SM, Park H, et al. Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis. 2013;23(8):785-791.
- Pacifico L, Anania C, Osborn J, et al. Low 25 (OH) D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603-611.
- Tang Z, Huang S, Ma R, Zheng H, Zhu Y. Low vitamin D status is associated with obesity but no other cardiovascular risk factors in Chinese children and adolescents. Nutr Metab Cardiovasc Dis. 2020;30(9):1573-1581.
- Nam GE, Kim DH, Cho KH, et al. Estimate of a predictive cut-off value for serum 25-hydroxyvitamin D reflecting abdominal obesity in Korean adolescents. Nutr Res. 2012;32(6):395-402.
- Reis JP, Von Mühlen D, Miller ER, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124(3):e371-e379.
- Alemzadeh R, Kichler J. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord. 2012;10(6):422-429.
- Moreira C, Moreira P, Abreu S, et al. Vitamin D intake and cardiometabolic risk factors in adolescents. Metab Syndr Relat Disord. 2014;12(3):171-177.
- Petersen RA, Dalskov S-M, Sørensen LB, et al. Vitamin D status is associated with cardiometabolic markers in 8-11-year-old children, independently of body fat and physical activity. Br J Nutr. 2015;114(10):1647-1655.
- Jalali-Farahani S, Amiri P, Akbar HM, Cheraghi L, Karimi M, Azizi F. Effects of a healthy lifestyle education on the incidence of metabolic syndrome in children during a 13-year follow-up. Int J Behav Med. 2018;25(1):131-140.
- Al-Daghri NM, Amer OE, Khattak MN, et al. Effects of different vitamin D supplementation strategies in reversing metabolic syndrome and its component risk factors in adolescents. J Steroid Biochem Mol Biol. 2019;191:105378.
- Makariou SE, Elisaf M, Challa A, Tellis C, Tselepis AD, Liberopoulos EN. Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: a pilot randomized study. Clin Nutr ESPEN. 2019;29:198-202.
- Ghobadi S, Rostami ZH, Marzijarani MS, Faghih S. Association of vitamin D status and metabolic syndrome components in Iranian children. Int J Prev Med. 2019:10.
- Mangge H, Zelzer S, Meinitzer A, et al. 25OH-vitamin D3 levels in obesity and metabolic syndrome-unaltered in young and not correlated to carotid IMT in all ages. Curr Pharm Des. 2015;21(17):2243-2249.
- Fu J, Han L, Zhao Y, et al. Vitamin D levels are associated with metabolic syndrome in adolescents and young adults: the BCAMS study. Clin Nutr. 2019;38(5):2161-2167.
- Wells G, Shea B, O'Connell D. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis; 2000.
- Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.
- Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57.
- Nam GE, Kim DH, Cho KH, et al. 25-hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr. 2014;17(1):186-194.
- Lee DY, Kwon AR, Ahn JM, et al. Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010. Ann Pediatr Endocrinol Metab. 2015;20(1):46-52.
- Kim Y-S, Hwang JH, Song MR. The association between vitamin D deficiency and metabolic syndrome in Korean adolescents. J Pediatr Nurs. 2018;38:e7-e11.
- Ganji V, Zhang X, Shaikh N, Tangpricha V. Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011;94(1):225-233.
- World Health Organization. Non communicable diseases. Available from: https://wwwwhoint/news-room/fact-sheets/detail/noncommunicablediseases Accessed 25 July 2019.
- (WHO) WHO. World Health Organization (WHO). NCD mortality and morbidity. Global Health Observatory (GHO) data. https://www.who.int/gho/ncd/mortality_morbidity/en/. 2016
- Cashman KD, Dowling KG, Škrabáková Z, et al. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044.
- Cashman KD. Vitamin D deficiency: defining, prevalence, causes, and strategies of addressing. Calcif Tissue Int. 2019;1-16.
- Schleicher RL, Sternberg MR, Looker AC, et al. National estimates of serum total 25-hydroxyvitamin D and metabolite concentrations measured by liquid chromatography-tandem mass spectrometry in the US population during 2007-2010. J Nutr. 2016;146(5):1051-1061.
- Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian health measures survey. Am J Clin Nutr. 2015;102(5):1044-1050.
- Stagi S, Pelosi P, Strano M, et al. Determinants of vitamin D levels in Italian children and adolescents: a longitudinal evaluation of cholecalciferol supplementation versus the improvement of factors influencing 25(OH)D status. Int J Endocrinol. 2014;2014:583039. https://doi.org/10.1155/2014/583039
- Çizmecioğlu FM, Etiler N, Görmüş U, Hamzaoğlu O, Hatun Ş. Hypovitaminosis D in obese and overweight schoolchildren. J Clin Res Pediatr Endocrinol. 2008;1(2):89-96.
- Rafraf M, Hasanabad SK, Jafarabadi MA. Vitamin D status and its relationship with metabolic syndrome risk factors among adolescent girls in Boukan, Iran. Public Health Nutr. 2014;17(4):803-809.
- Hu Y, Chen J, Wang R, et al. Vitamin D nutritional status and its related factors for Chinese children and adolescents in 2010-2012. Nutrients. 2017;9(9):1024.
- Saneei P, Salehi-Abargouei A, Esmaillzadeh A. Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis. Obes Rev. 2013;14(5):393-404.
- Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr. 2010;64(12):1457-1464. https://doi.org/10.1038/ejcn.2010.176
- Karhapää P, Pihlajamäki J, Pörsti I, et al. Diverse associations of 25-hydroxyvitamin D and 1, 25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med. 2010;268(6):604-610.
- Mai X-M, Videm V, Sheehan NA, Chen Y, Langhammer A, Sun Y-Q. Potential causal associations of serum 25-hydroxyvitamin D with lipids: a Mendelian randomization approach of the HUNT study. Eur J Epidemiol. 2019;34(1):57-66.
- Di Angelantonio ESN, Perry P, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA. 2009;18(302):1993-2000. https://doi.org/10.1001/jama.2009.1619
- Boekholdt SM, Arsenault BJ, Hovingh GK, et al. Levels and changes of HDL cholesterol and apolipoprotein AI in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation. 2013;128(14):1504-1512.
- Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89:387-392.
- Ardeshir Larijani F, Kalantar Motamedi SM, Keshtkar AA, et al. The relation between serum vitamin D levels and blood pressure: a population-based study. Acta Med Iran. 2014;52(4):290-297.
1927 visitors, last modified 07 Jul, 2021, |